Endo completes tender offer for Indevus
Executive Summary
Endo completes tender offer for outstanding shares of Indevus Pharmaceuticals common stock via subsidiary BTB Purchaser Inc., the firm announces March 19. More than 70 million (nearly 89 percent) of Indevus' outstanding shares were "validly tendered" at the close of business March 18. Endo also is effecting a short-form merger between BTB and Indevus (with Indevus continuing as a wholly owned subsidiary of Endo) to complete the acquisition of 100 percent of Indevus' common stock
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.